Detalhe da pesquisa
1.
Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease.
Cardiovasc Diabetol
; 22(1): 72, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36978066
2.
Acute Decompensated Heart Failure in the Setting of Acute Coronary Syndrome.
JACC Heart Fail
; 10(6): 404-414, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35654525
3.
Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical Trials.
JAMA Netw Open
; 4(7): e2117963, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297072
4.
Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction.
J Am Coll Cardiol
; 43(4): 549-56, 2004 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-14975462
5.
Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial.
J Am Coll Cardiol
; 41(8): 1251-60, 2003 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-12706917
6.
Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study).
Am J Cardiol
; 93(5): 636-9, 2004 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14996598
7.
End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience.
Circ Cardiovasc Qual Outcomes
; 6(4): 470-8, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23759472